Lägg till i kalendern

Interactive webinar: Please send an email to [email protected] to sign up for the meeting and to receive the link and instructions on how to join.

Approval must be obtained from head of clinic for participation.

Program 
15:00-15:10
Welcome (introduction and technical walkthrough of the voting system
Per Karlsson
15:10-15:35
Overview of Nordic treatment landscape
Per Karlsson
15:35-15:40
Welcome to and introduction of Fabrice André
Hans Petter Eikesdal
15:40-16:40
PIK3CA mutations in ABC patients
Fabrice André
16:40-16:50
Bio break
16:50-17:00
Importance of testing, what do you do today? (interactive voting)
Hans Petter Eikesdal
17:00-17:20
Mutation testing for HR+/HER2- aBC – When and What?
Anne-Vibeke Lænkholm
17:20-17:40
Treatment sequencing – Panel discussion
Minna Tanner
17:40-17:45
Wrap up and evaluation
Minna Tanner
Per Karlsson, MD, PhD
Sahlgrenska University Hospital, Gothenburg, Sweden
Hans Petter Eikesdal, MD, PhD
Haukeland University Hospital, Bergen, Norway
Fabrice André MD, PhD
Institute Gustave Roussy, Paris, France
Anne-Vibeke Lænkholm MD
Zealand University Hospital, Roskilde, Denmark
Minna Tanner MD, PhD
Tampere University Hospital, Tampere, Finland
SE2009227143 (September 2020)
×

Medical Information Request

×

Ask Speakers